4//SEC Filing
BEDU-ADDO FRANK 4
Accession 0001140361-21-021503
CIK 0001472091other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 7:26 PM ET
Size
8.3 KB
Accession
0001140361-21-021503
Insider Transaction Report
Form 4
BEDU-ADDO FRANK
DirectorPresident/CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−53,174→ 0 totalExercise: $6.57Exp: 2021-07-27→ Common Stock (53,174 underlying) - Exercise/Conversion
Common Stock
2021-06-15$6.57/sh+53,174$349,353→ 673,681 total - Tax Payment
Common Stock
2021-06-15$12.86/sh−27,166$349,355→ 646,515 total
Footnotes (2)
- [F1]On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021.
- [F2]The Stock Option is fully vested in accordance with its terms.
Documents
Issuer
PDS Biotechnology Corp
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001770756
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 7:26 PM ET
- Size
- 8.3 KB